SLE patients with lupus nephritis had no differences in the percentages of IFN-γ-producing CD134+CD4+ T-cells as compared to HC (25.4 ± 11.4% vs. 29.2 ± 19.4%; p = 0.99). This evidence concerns the gene TNFRSF4 and systemic lupus erythematosus.